日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial

维利诺德联合别嘌醇治疗慢性肾脏病：一项随机、安慰剂和活性药物对照试验

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.0000000000000326
Heerspink, Hiddo J L; Stack, Austin G; Terkeltaub, Robert; Jongs, Niels; Inker, Lesley A; Bjursell, Magnus; Maklad, Noha; Perl, Shira; Eklund, Olof; Rikte, Tord; Sjöström, C David; Perkovic, Vlado
发表日期：2024
文献求助 收藏

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia

SAPPHIRE 是一项随机、对照的 IIb 期研究，旨在评估维利尿素联合别嘌醇治疗慢性肾脏病合并高尿酸血症患者的疗效，研究背景、设计、人口统计学特征和基线特征如下。

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfab237
Heerspink, Hiddo J L; Stack, Austin G; Terkeltaub, Robert; Greene, Tom A; Inker, Lesley A; Bjursell, Magnus; Perl, Shira; Rikte, Tord; Erlandsson, Fredrik; Perkovic, Vlado
APP
发表日期：2022
文献求助 收藏

Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism

无需按按钮即可注射：盾牌触发注射机制的探索性研究

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13203
Zijlstra, Eric; Coester, Hans-Veit; Heise, Tim; Plum-Mörschel, Leona; Rasmussen, Ole; Rikte, Tord; Pedersen, Line Kynemund; Qvist, Marianne; Sparre, Thomas
发表日期：2018
文献求助 收藏

Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial

速效门冬胰岛素与门冬胰岛素在接受持续皮下胰岛素输注的1型糖尿病患者中的药理学特性比较：一项随机、双盲、交叉试验

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12803
Heise, Tim; Zijlstra, Eric; Nosek, Leszek; Rikte, Tord; Haahr, Hanne
代谢
糖尿病
免疫/内分泌
发表日期：2017
文献求助 收藏